AzIMI et al., Orient. J. Chem., Vol. 29(4), 1443-1448 (2013)
1447
ethanol yellow needles (85%), m.p:156-158 ºC, after
recrystalization from ethanol.
1-(2-(4-bromophenylamino)-6-nitroimidazo[1,2-a]
pyridine-3-yl) ethanone (2, x: br)
Pyrolysis (580°C, 0.01 mm Hg, sublimation
flask 110°C, 60 min) of isoxazolone (1, X: Br) (100
mg, 0.23 mmol) gave pale cream needles (81.17
mg, 90%), m.p: 195-196 ºC.
1H-NMR (CDCl3)δ(ppm) 2.29 (s,J=7.05Hz,
3H, CH3), 2.35 (s, 3H, Me), 7.04 (d, J=8.5Hz, 2H,
Ar), 7.07 (d, J=8.5Hz, 2H, Ar), 7.54 (d, J= 9.0Hz, 1H,
Ar), 8.55 (dd, J1=9.0Hz, J2=2.5Hz, 1H, Ar), 8.91 (d,
J=2.5Hz, 1H, Ar), 10.33 (s, 1H, NH).
1H-NMR(D6-DMSO)δ(ppm)2.55(s, J=7.0Hz,
3H, CH3), 7.49 (d, J=8.5Hz, Ar), 7.68 (d, J=9.7Hz,
1H, Ar), 7.74 (d, J=8.5Hz , 2H, Ar), 8.19 (dd,
J1=9.7Hz, J2=1.6Hz, 1H, Ar), 8.87 (bd, J=1.6Hz, 1H,
Ar), 9.88 (s,1H,NH).
13C-NMR (CDCl3)δ(ppm) 14.66, 21.35,
79.05, 115.42, 122.40, 130.29, 134.74, 135.36,
136.83, 141.89, 143.92, 154.28, 160.88, 163.62,
164.19.
13C-NMR (D6-DMSO)δ(ppm)15.25, 99.72,
114.62, 114.97, 121.76, 123.93, 127.61, 132.38,
137.66, 140.01, 147.17, 155.28, 160.87.
FT-IR νmax 3177, 1762, 1700, 1600, 1515,
1338, 1208, 1123, 976, 838 cm-1.
MS m/z 355(M+, 13%), 354(100), 294(57),
269(16), 248(40), 230(16), 220(16), 158(39),
144(13), 118(21), 117(20), 107(16), 91(67), 78(16),
65(20), 44(33).
FT-IR νmax 3285, 2955, 1643, 1611, 1555,
1475, 1331, 1294, 1201, 1102, 1079, 1002, 820
cm-1.
MS m/z 375(M+, 62%), 374(M+,64%),
360(5), 358(6), 279(100), 251(16), 233(14), 205(12),
184(11), 182(12), 157(12), 155(12), 102(14), 78(13),
77(11).
4-acetyl-3-(4-methoxy phenylamino) -2-(5-
nitropyridin-2-yl) isoxazol-5(2H)-ones (1, x:
OMe).
This compound was prepared as described
for above using the corresponding isoxazolone (6, X:
OMe) and 2-chloro-5-nitropyridine to give the desired
product Yellow needles (80%), m.p: 186-188 ºC.
1 - ( 2 - ( 4 - m e t h y l
-6-nitroimidazo[1,2-a] pyridine-3-yl) ethanone
(2, x:Me)
p h e n y l a m i n o )
Pyrolysis (580°C, 0.01 mm Hg, sublimation
1H-NMR (CDCl3)δ(ppm) 2.30 (s, J=7.0Hz,
3H, CH3), 3.77 (s, 3H, OMe), 6.79 (d, J=8.7Hz,
2H,Ar), 7.10 (d, J=8.7Hz, 2H, Ar), 7.52 ( d, J=9.0Hz,
1H, Ar), 8.54 (dd, J1=9Hz, J2=2.1Hz, 1H, Ar), 8.93
(bd, J=2.1Hz, 1H, Ar), 10.26 (s,1H,NH).
flask 110°C, 60 min) of isoxazolone
(1, X: Me)
(100 mg, 0.26 mmol) gave the desired imidazole as
pale cream needles (82.34 mg, 93%), m.p: 187-188
ºC.
1H-NMR (D6-DMSO)δ(ppm) 2.35 (s,
J=6.9Hz, 3H, CH3), 2.55 (s, 3H, Me), 7.19 (d,
J=8.2Hz, 2H, Ar), 7.51 (d, J=9.7Hz, 1H, Ar), 7.59
(bd, J=8.2Hz, 2H, Ar), 8.15 (bd, J=6.7Hz, 1H, Ar),
8.85 (bs, 1H, NH), 9.84 (bs, 1H, Ar).
13C-NMR (CDCl3)δ(ppm) 14.72, 55.89,
78.87, 114.85, 115.59, 124.34, 130.74, 134.68,
141.93, 143.95, 154.33, 158.40, 161.38, 163.69,
164.32.
FT-IR νmax 3823, 1785, 1700, 1592, 1345,
13C-NMR (CDCl3)δ(ppm): 15.03, 61.44,
98.99, 114.30, 119.33, 122.80, 127.26, 130.07,
132.93, 137.11, 147.34, 157.76, 161,15 .
1207, 1115, 1030, 838 cm-1.
MS m/z 370 (M+, 10%), 356(100), 310(49),
295(43), 264(21), 249(13), 221(14), 193(12),
194(10), 174(21), 146(10), 134(34), 133(22),
123(17), 92(16), 77(29), 44(37).
FT-IR νmax 3455, 1662, 1608, 1555, 1308,
1208, 1015, 822 cm-1.
MS m/z 310 (M+, 100%), 294(48), 248(27),
220(9), 144(10), 118(13), 91(20), 78(6), 65(6).